Physician
Inland Imaging LLC
Inland Imaging LLC was paid $6.82M by Medicaid between Jan 2018 and Dec 2024, across 82 billing codes. Its largest line is 77067, Screening mammography, bilateral, including computer-aided detection — 31% of everything it billed.
33Billing provider infoINLAND IMAGING LLC
SPOKANE, WA 99202
SPOKANE, WA 99202
33aNPI1851352348assigned 04/01/2006
33bProvider typeDiagnostic Radiology Physician
28Total paid$6.82M
24GClaims152,373
24DCodes billed82
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Diagnostic Radiology Physician providers in Washington
Rank by total paid#3 of 56
Median peer was paid$32K
This provider vs. median215×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 26,117 | $1.22M | |
| 2019 | 22,495 | $1.05M | |
| 2020 | 15,540 | $732K | |
| 2021 | 19,754 | $923K | |
| 2022 | 22,989 | $1.00M | |
| 2023 | 25,001 | $1.07M | |
| 2024incomplete | 20,477 | $802K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 77067 | Screening mammography, bilateral, including computer-aided detection | 31% | 23,570 | 23,212 | $2.12M |
| 76642 | 9.1% | 12,130 | 10,745 | $620K | |
| 76830 | Ultrasound, transvaginal | 7.3% | 6,668 | 6,521 | $497K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 7.1% | 10,201 | 9,795 | $487K |
| 77066 | Tomosynthesis, mammo | 4.2% | 2,852 | 2,762 | $283K |
| 71046 | Radiologic examination, chest; 2 views | 4.0% | 14,971 | 14,447 | $270K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 3.8% | 2,187 | 2,055 | $260K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 3.5% | 1,399 | 1,340 | $242K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 3.2% | 3,323 | 3,241 | $219K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 2.9% | 1,973 | 1,880 | $197K |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 2.5% | 7,323 | 7,154 | $169K |
| 77065 | Tomosynthesis, mammo | 2.1% | 1,741 | 1,652 | $141K |
70 more codes
| 76536 | 1.8% | 1,854 | $123K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 1.6% | 1,639 | $111K |
| 71250 | 1.4% | 1,557 | $92K | |
| 72100 | 1.1% | 3,439 | $74K | |
| 71271 | 1.1% | 818 | $72K | |
| 76770 | 1.0% | 1,124 | $69K | |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 2,976 | $68K |
| 73630 | <1% | 3,325 | $62K | |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | <1% | 2,732 | $60K |
| 73030 | <1% | 3,270 | $57K | |
| 73562 | <1% | 2,500 | $55K | |
| 72110 | <1% | 1,531 | $39K | |
| 77002 | <1% | 529 | $29K | |
| 73610 | <1% | 1,306 | $27K | |
| 73130 | <1% | 1,350 | $27K | |
| 78264 | <1% | 129 | $25K | |
| 72040 | <1% | 1,166 | $25K | |
| 76801 | <1% | 300 | $23K | |
| 72141 | <1% | 229 | $23K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 240 | $20K |
| A9541 | Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries | <1% | 114 | $20K |
| 74183 | <1% | 117 | $17K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,369 | $16K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 111 | $16K |
| 76882 | <1% | 546 | $15K | |
| 73502 | <1% | 641 | $15K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 19,825 | $13K |
| 74018 | <1% | 741 | $13K | |
| 73110 | <1% | 503 | $11K | |
| G0297 | Low dose ct scan (ldct) for lung cancer screening | <1% | 96 | $10K |
| 93971 | <1% | 160 | $10K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 154 | $9K |
| 73221 | <1% | 71 | $8K | |
| 72050 | <1% | 295 | $7K | |
| 77080 | <1% | 330 | $6K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 54 | $6K |
| 73564 | <1% | 255 | $6K | |
| 73522 | <1% | 174 | $5K | |
| 78227 | <1% | 12 | $3K | |
| 72070 | <1% | 191 | $3K | |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | <1% | 25 | $3K |
| 72082 | <1% | 72 | $3K | |
| 72072 | <1% | 93 | $2K | |
| 78320 | <1% | 18 | $2K | |
| J2805 | Injection, sincalide, 5 micrograms | <1% | 12 | $2K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 24 | $1K |
| 73140 | <1% | 54 | $1K | |
| A9503 | Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries | <1% | 95 | $1K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 13 | $836.64 |
| A9537 | Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries | <1% | 13 | $573.40 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 70 | $488.57 |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 12 | $441.89 |
| 74019 | <1% | 25 | $439.08 | |
| 73700 | <1% | 13 | $432.59 | |
| 99152 | <1% | 14 | $168.70 | |
| 71045 | Radiologic examination, chest; single view | <1% | 13 | $100.53 |
| 99153 | Mod sedat endo service >5yrs | <1% | 12 | $37.11 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 27 | $13.97 |
| J3490 | Unclassified drugs | <1% | 29 | $13.00 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 12 | $2.12 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 14 | $1.30 |
| 3341F | 0% | 696 | $0.00 | |
| G9637 | Final reports with documentation of one or more dose reduction techniques (e.g., automated exposure control, adjustment of the ma and/or kv according to patient size, use of iterative reconstruction technique) | 0% | 596 | $0.00 |
| G9557 | Final reports for ct, cta, mri or mra studies of the chest or neck without an incidentally found thyroid nodule < 1.0 cm noted or no nodule found | 0% | 243 | $0.00 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 541 | $0.00 |
| G9551 | Final reports for imaging studies without an incidentally found lesion noted | 0% | 2,383 | $0.00 |
| 3342F | 0% | 89 | $0.00 | |
| 3340F | 0% | 27 | $0.00 | |
| G9322 | Count of previous ct and cardiac nuclear medicine (myocardial perfusion or infarct avid imaging) studies not documented in the 12-month period prior to the current study, reason not given | 0% | 15 | $0.00 |
| G9500 | Radiation exposure indices documented in final report for procedure using fluoroscopy | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWILSON, KATHLEEN (COO)
| Provider | Location | Paid |
|---|---|---|
| Aging Services, INC. | Norman, OK | $1.16M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.